What is the typical dose of Keflex (Cephalexin) for urinary tract infections or skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) Dosing

For uncomplicated urinary tract infections in adults, cephalexin 500 mg twice daily for 7-14 days is as effective as the traditional four-times-daily dosing and should be preferred for improved adherence. 1, 2

Urinary Tract Infections

Uncomplicated Cystitis (Adults >15 years)

  • Standard dosing: 500 mg every 12 hours (twice daily) for 7-14 days 1
  • The FDA label specifies this regimen for uncomplicated cystitis in patients over 15 years of age 1
  • A 2023 study demonstrated that twice-daily dosing (500 mg BID) achieved equivalent treatment failure rates (12.7%) compared to four-times-daily dosing (17%), with no statistical difference (P = 0.343) 2
  • The twice-daily regimen offers better adherence without compromising efficacy 2

Alternative Dosing for UTI

  • Traditional regimen: 250 mg every 6 hours (four times daily) 1
  • For more severe infections or less susceptible organisms, larger doses may be needed 1
  • Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses, far exceeding the minimum inhibitory concentration for typical urinary pathogens 3

Renal Impairment Considerations

  • Patients with creatinine clearance <30 mL/min require dose reduction proportional to reduced renal function 3
  • 70-100% of cephalexin is excreted unchanged in urine within 6-8 hours 3

Skin and Soft Tissue Infections

Uncomplicated Skin Infections (Adults)

  • Standard dosing: 500 mg every 12 hours (twice daily) 1
  • This applies to streptococcal pharyngitis and skin/skin structure infections 1

Methicillin-Susceptible Staphylococcus aureus (MSSA)

  • Dosing: 500 mg four times daily (QID) orally 4
  • Cephalexin is recommended for penicillin-allergic patients except those with immediate hypersensitivity reactions 4
  • The availability of suspension formulation and less frequent dosing requirements make it practical for outpatient use 4

Severe or Complicated Skin Infections

  • For infections requiring >4 g daily, parenteral cephalosporins should be considered instead 1
  • The usual adult dosage range is 1-4 g daily in divided doses 1

Pediatric Dosing

General Pediatric Dosing

  • Standard range: 25-50 mg/kg/day in divided doses 1
  • For streptococcal pharyngitis and skin infections in children >1 year, the total daily dose may be divided every 12 hours 1

Specific Pediatric Indications

  • Otitis media: 75-100 mg/kg/day in 4 divided doses 1
  • Severe infections: Double the standard dosage 1
  • β-hemolytic streptococcal infections: Administer therapeutic dosage for at least 10 days 1

Pediatric UTI

  • A 3-day course of cephalexin 25-50 mg/kg/day achieved 90% immediate cure rates for acute lower urinary tract infections in children 5
  • However, the FDA-approved duration for cystitis is 7-14 days 1

Important Clinical Considerations

Absorption and Administration

  • Cephalexin is not absorbed from the stomach but is totally and rapidly absorbed in the upper intestine 3
  • Can be administered in relatively high oral doses without gastrointestinal irritation 3
  • Does not disturb lower bowel flora due to absorption high in the intestinal tract 3

Common Pitfalls to Avoid

  • Do not use cephalexin for MRSA infections—it is only effective against methicillin-susceptible strains 4
  • Do not exceed 4 g daily without switching to parenteral cephalosporins 1
  • Do not forget dose adjustment in patients with creatinine clearance <30 mL/min 3
  • Children may require higher doses per kilogram than adults due to greater body water turnover 3

Adverse Effects

  • Generally mild and transient, including gastrointestinal disturbances, diarrhea, nausea, and vomiting 6
  • Low incidence of allergy due to chemical stability and configuration 3
  • Reported adverse events occurred in only 4.6-5.6% of patients in recent UTI studies 2

References

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Three-day therapy with cephalexin for lower urinary tract infections in children.

Scandinavian journal of infectious diseases, 1984

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.